Renalytix Plc

RENX:LNLondon Stock Exchange

Overview

Company Profile

Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Our goal is to lower healthcare costs and improve patient quality of life by transforming the paradigm for kidney disease risk assessment and clinical management through our KidneyIntelX platform. 2 P's on a Pod: Small Cap Investing with Paul Hill & Paul Scott Sep 11, 2026

Classification

SectorHealthcare
ExchangeLondon Stock Exchange
IndustryHealthcare Providers & Services